Mylan seeks nod for two biosimilars

Mylan seeks nod for two biosimilars

Biotechnology firm Biocon said its partner Mylan has re-submitted marketing authorisation applications with the European drug regulator European Medicines Agency for two biosimilars Trastuzumab and Pegfilgrastim, reports PTI from New Delhi.